Share Prices & Company Research

Stockbroking

Akers Biosciences Inc

Current Price 24.44p Bid 24.00p Ask 28.00p Change 0.00%
Last Updated: 22/06/2018 19:46. Prices delayed by at least 15 minutes.
Call 0113 243 6941 or search for your local office

Company Overview

Akers Biosciences, Inc. develops, manufactures, and supplies rapid screening and testing products designed to deliver quicker and more cost-effective healthcare information to healthcare providers and consumers. The Company has advanced the science of diagnostics while responding to major shifts in healthcare through the development of several proprietary platform technologies. The Company's state-of-the-art rapid diagnostic assays can be performed virtually anywhere in minutes when time is of the essence. The Company has aligned with major healthcare companies and high volume medical product distributors to maximize product offerings, and to be a major worldwide competitor in diagnostics.

Financial Highlights Year Ended 31/12/2017

Turnover
£3.93m
Operating Profit
£-5.05m
Dividend Yield
0.00
Dividend Per Share
0.00
Dividend Cover
0.00
P/E Ratio
-0.43

Key Personnel

John J Gormally
Chief Executive Officer
Thomas James Knox
Non-Executive Chairman
Richard Carlyle Tarbox III
Non-Executive Chairman
Brandon Thomas Knox
Non-Executive Director
Robert Ernest Andrews
Non-Executive Director
Dr Syed Raza Bokhari
Non-Executive Director

Stock Details

EPIC
AKR
ISIN
US00973E1029
Shares in Issue
90,944,268
Market cap
£23.65m

Analyst Views (1)

Strong Buy
 
0.00%
Buy
 
0.00%
Hold
 
100.00%
Sell
 
0.00%
Strong Sell
 
0.00%
The above information represents a selection of the views published in the last 120 days by analysts. It is subject to change without notice and doesn't reflect view held by Redmayne Bentley and is not advice.

Price Summary

Mid Price
26.00p
Bid Price
24.00p
Ask Price
28.00p
Volume
6200
Change Today
0.00p
% Change Today
0.00%
Open
26.50p
Previous Close
26.00p
Intraday High
26.50p
Intraday Low
24.44p
52 Week High
105.00p
52 Week Low
15.00p
52 week high and low figures quoted above are calculated from intraday price data.

Intra-Day Chart

Akers Biosciences Inc Intra-day Chart

Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Tangible Assets
0.2
0.3
Intangible Assets & Goodwill
1.1
1.3
Investments & Other Non-Current Assets
0.2
0.3
Total Non-Current Assets
1.6
1.9
Inventory
1.9
2.0
Trade & Receivables
1.6
0.7
Cash & Receivables
0.4
0.1
Other Current Assets & Assets Held for Resale
5.4
0.4
Total Assets
10.9
5.1

Liabilities (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Short Term Liabilities
1.8
1.7
Long Term Liabilities
0.0
0.0
Other Liabilities / Pension etc
0.0
0.0
Total Liabilities
1.8
1.7

Net Assets (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Net Assets
9.1
3.4

Equity (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Share Capital
1.8
100.9
Minority Interests
0.0
0.0
Retained Earnings
-103.3
-97.5
Share Premium Account
0.0
0.0
Other Equity
110.6
0.0
Total Equity
9.1
3.4

Cashflow (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Cashflow from Operating Activities
-5.1
-4.2
Cashflow Before Financing
-10.1
-0.3
Increase / Decrease in Cash
0.4
-0.3

Income (£m)

Data has been provided by MoneyAM

Reporting Date
31 Dec 2017
31 Dec 2016
Turnover
3.9
3.0
Cost of Sales
1.4
1.1
Gross Profit
2.5
1.9
Operating Profit
-5.1
-3.3
Pre-Tax Profit
-5.8
-3.3
Profit / Loss for the Year
-5.8
-3.3
The value of your investments and the income from them may go down as well as up, and you could get back less than you invested.
We use cookies on this site to improve your experience and help us provide you with a better website. An explanation of the cookies we use and their purpose can be found within our Cookie Policy. Your continued use of this site means you consent to the use of cookies.